Clinical Edge Journal Scan

Serum 25-hydroxyvitamin D levels inversely correlated with albuminuria in patients with diabetes


 

Key clinical point: Serum level of 25-hydroxyvitamin D (25[OH]D) was inversely associated with albuminuria as an indicator of diabetic nephropathy in patients with type 2 diabetes mellitus (T2D), with the prevalence of macroalbuminuria increasing when the serum 25(OH)D level was <20 ng/mL.

Major finding: A strong negative association was observed between the serum 25(OH)D level and severity of albuminuria ( r, 0.257; P < .001), with the prevalence of vitamin D deficiency being 61.8%, 33.3%, and 24.0% in patients with macroalbuminuria, microalbuminuria, and normoalbuminuria, respectively.

Study details: This was a cross-sectional study including 200 patients with T2D, of which 100, 66, and 34 had normoalbuminuria, microalbuminuria, and macroalbuminuria, respectively.

Disclosures: This study was supported by Shiraz University of Medical Sciences, Iran. The authors declared no competing interests.

Source: Zomorodian SA et al. Assessment of the relationship between 25-hydroxyvitamin D and albuminuria in type 2 diabetes mellitus. BMC Endocr Disord. 2022;22:171 (Jul 4). Doi: 10.1186/s12902-022-01088-2

Recommended Reading

Remnant cholesterol captures residual CV risk in patients with T2D
Type 2 Diabetes ICYMI
T2D: Significant improvement in glycemic control with efpeglenatide
Type 2 Diabetes ICYMI
Semaglutide improves glycemic control in patients with prediabetes
Type 2 Diabetes ICYMI
SGLT2i vs GLP-1RA or DPP4i lowers the risk for new-onset AF in T2D
Type 2 Diabetes ICYMI
DPP4 inhibitor ups risk for cholecystitis in T2D
Type 2 Diabetes ICYMI
Initiating semaglutide improves outcomes in patients on high daily doses of insulin
Type 2 Diabetes ICYMI
Prusogliptin add-on to metformin safe and effective in T2D
Type 2 Diabetes ICYMI
SGLT2i vs DPP4i lowers death risk in T2D
Type 2 Diabetes ICYMI
Real-world insights of initiating or switching to insulin degludec/aspart in T2D
Type 2 Diabetes ICYMI
Sarcopenia index significantly linked to subclinical atherosclerosis prevalence in T2D
Type 2 Diabetes ICYMI